Literature DB >> 16634368

Lupus nephritis and renal disease in pregnancy.

S Germain1, C Nelson-Piercy.   

Abstract

Management of pregnant women with renal disease involves awareness of, and allowance for, physiological changes including decreased serum creatinine and increased proteinuria. For women with systemic lupus erythematosus (SLE), pregnancy increases likelihood of flare. These can occur at any stage, and are more difficult to diagnose, as symptoms overlap those of normal pregnancy. Renal involvement is no more common in pregnancy. Worsening proteinuria may be lupus flare but differential includes pre-eclampsia. In women with chronic renal disease, pregnancy may accelerate decline in renal function and worsen hypertension and proteinuria, with increased risk of maternal (eg, pre-eclampsia) and fetal (eg, IUGR, IUD) complications, strongly correlating with degree of renal impairment peri-conception. Pregnancy success rate varies from 20% to 95% depending on base-line creatinine. Best outcome is obtained if disease was quiescent for >6 months pre-conception. Women on dialysis or with renal transplants can achieve successful pregnancy but have higher maternal and fetal complication rates. Acute on chronic renal failure can develop secondary to complications such as HELLP and AFLP. Management needs to be by a multidisciplinary team involving physicians and obstetricians, ideally beginning with pre-pregnancy counselling. Treatment of flares includes corticosteroids, hydroxychloroquine, azothioprine, NSAIDs and MME Blood pressure is controlled with methyldopa, nifedipine or hydralazine.

Entities:  

Mesh:

Year:  2006        PMID: 16634368     DOI: 10.1191/0961203306lu2281rr

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  17 in total

Review 1.  The role of antimalarial agents in the treatment of SLE and lupus nephritis.

Authors:  Senq-J Lee; Earl Silverman; Joanne M Bargman
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

Review 2.  Lupus and pregnancy: complex yet manageable.

Authors:  Josephine Patricia Dhar; Robert J Sokol
Journal:  Clin Med Res       Date:  2006-12

3.  Placental Nkx2-5 and target gene expression in early-onset and severe preeclampsia.

Authors:  Elena R Rivers; Anthony J Horton; Angela F Hawk; Elizabeth G Favre; Katherine M Senf; Paul J Nietert; Eugene Y Chang; Ann C Foley; Christopher J Robinson; Kyu-Ho Lee
Journal:  Hypertens Pregnancy       Date:  2014-07-02       Impact factor: 2.108

4.  Update on systemic lupus erythematosus pregnancy.

Authors:  Irene Iozza; Stefano Cianci; Angela Di Natale; Giovanna Garofalo; Anna Maria Giacobbe; Elsa Giorgio; Maria Antonietta De Oronzo; Salvatore Politi
Journal:  J Prenat Med       Date:  2010-10

Review 5.  Angiogenic factors in preeclampsia: potential for diagnosis and treatment.

Authors:  Arvind Goel; Sarosh Rana
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-11       Impact factor: 2.894

6.  Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products.

Authors:  Eleazar Soto; Roberto Romero; Karina Richani; Jimmy Espinoza; Tinnakorn Chaiworapongsa; Jyh Kae Nien; Sam S Edwin; Yeon Mee Kim; Joon Seok Hong; Luis F Goncalves; Lami Yeo; Moshe Mazor; Sonia S Hassan; Juan Pedro Kusanovic
Journal:  J Matern Fetal Neonatal Med       Date:  2010-07

7.  Preeclampsia, dilated cardiomyopathy and renal failure as the first manifestation of systemic lupus erythematosus: a case report.

Authors:  J Stepanková; M Bürgelova; E Honsova; V Tesar; J Vrbska; O Viklicky
Journal:  Clin Rheumatol       Date:  2008-12-12       Impact factor: 2.980

8.  Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies.

Authors:  Juan Pedro Kusanovic; Roberto Romero; Sonia S Hassan; Francesca Gotsch; Samuel Edwin; Tinnakorn Chaiworapongsa; Offer Erez; Pooja Mittal; Shali Mazaki-Tovi; Eleazar Soto; Nandor Gabor Than; Lara A Friel; Bo Hyun Yoon; Jimmy Espinoza
Journal:  J Matern Fetal Neonatal Med       Date:  2007-12

Review 9.  Angiogenic factors in diagnosis, management, and research in preeclampsia.

Authors:  Sarosh Rana; S Ananth Karumanchi; Marshall D Lindheimer
Journal:  Hypertension       Date:  2013-10-28       Impact factor: 10.190

Review 10.  The pathophysiology of hypertension in systemic lupus erythematosus.

Authors:  Michael J Ryan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-01-21       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.